Vaccines

EU Commission Approves Pfizer's ABRYSVO™ for Infant and Elderly RSV Protection

Pfizer Inc. (NYSE: PFE) announced today that the European Commission (EC) has granted marketing authorization for ABRYSVO™, the company’s bival...

 August 25, 2023 | News

SK Bioscience and Vaxxas Partner for Needle-Free Typhoid Vaccine Patch

SK bioscience and Vaxxas have officially entered into a Joint Development Agreement. This collaboration is set to revolutionize vaccine delivery by devel...

 August 24, 2023 | News

Satio Partners with BARDA DRIVe for Patch-Based Ebola Diagnostic

This groundbreaking diagnostic will combine Satio's patch-based blood collection device with Institut Pasteur de Dakar's sensitive and rapid...

 August 21, 2023 | News

Nagasaki University & NEC OncoImmunity Partner for Universal Vaccines Against Tropical Diseases

The collaboration between NOI and Nagasaki University aims to harness the power of advanced AI to optimize vaccine designs to be universally and broadly pr...

 August 21, 2023 | News

Pfizer's Pneumococcal 20-Valent Conjugate Vaccine is Now Available in Hong Kong

First pneumococcal conjugate vaccine that fights against 20 serotypes leading to most of the invasive pneumococcal diseases and pneumonia[2],[3] &md...

 August 11, 2023 | News

SK bioscience Announces Equity Investment in Novavax to Strengthen Strategic Partnership

SK bioscience makes a strategic equity investment in Novavax to respond to the endemic situation and strengthen their strategic partnership. SK bioscien...

 August 09, 2023 | News

Zuellig Pharma Singapore and GSK Establish Vaccine Distribution Hub to Improve Asia’s Access to Vaccines

Zuellig Pharma today announced that it has entered into an agreement with global biopharma company, GSK, to help set up its first vaccine distribution ...

 August 01, 2023 | News

Recbio's Novel Adjuvanted Shingles Vaccine Receives Clinical Trial Approval in China and Progresses Overseas

The Company proposes to adopt a randomized, double-blind, Shingrix® parallel controlled phase I clinical trial in 180 healthy adult subjects aged 40 an...

 July 27, 2023 | News

VBI Vaccines’ Fight Against Hep B Expands Globally

Brii Biosciences has acquired worldwide exclusive license to VBI-2601 and an exclusive license for PreHevbri in the Asia Pacific region VBI will rece...

 July 06, 2023 | News

Meissa Vaccines Signs CGMP Manufacturing Agreement for Pediatric RSV Vaccine in Phase 2 Trials

Under the agreement, Exothera will manufacture Meissa’s MV-012-968 vaccine candidate under Current Good Manufacturing Practice (CGMP) regulations to ...

 July 06, 2023 | News

Brii Biosciences Expands Hepatitis B Leadership with Comprehensive Portfolio from Prevention to Cure

Company also acquires exclusive rights to PreHevbri®, a clinically differentiated, 3-antigen prophylactic vaccine, from VBI in Greater China ...

 July 06, 2023 | News

SK Bioscience and Government Pharmaceutical Organization Strengthen Vaccine Infrastructure in Thailand

SK bioscience and the Government Pharmaceutical Organization agreed to establish a pandemic response platform, encompassing not only Thailand but extendi...

 July 05, 2023 | News

SK bioscience and the Peter Doherty Institute for Infection and Immunity Join Forces Against Influenza

SK bioscience will collaborate with one of the world’s leading biomedical research institutes, the Peter Doherty Institute for Infection and Immunity...

 June 27, 2023 | News

SK bioscience COVID-19 Vaccine Granted Emergency Use Listing by the World Health Organization

In a Phase III trial, the vaccine demonstrated neutralizing antibody responses against SARS-CoV-2 parental strain and had a standard safety and reactogen...

 June 19, 2023 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close